Pataxel 30mg, 100mg & 300mg injection vial

Paclitaxel is an antimicrotubule agent that promotes the assembly of microtubules from tubulin dimers and stabilises microtubules by preventing depolymerisation.

Share Now

Additional Information

NamePataxel
DescriptionPaclitaxel is an antimicrotubule agent that promotes the assembly of microtubules from tubulin dimers and stabilises microtubules by preventing depolymerisation. This stability inhibits the normal dynamic reorganisation of the microtubule network, which is essential for vital interphase and mitotic cellular functions. In addition, paclitaxel induces abnormal arrays or bundles of microtubules throughout the cell cycle and multiple asters of microtubules during mitosis.
Active IngredientPaclitaxel
IndicationPaclitaxel in combination therapy is indicated for:

  • Ovarian carcinoma
  • Breast carcinoma
  • Advanced non-small cell lung carcinoma
  • AIDS-related Kaposi’s sarcoma
Strengths30mg, 100mg & 300mg injection vial
Business PartnerMylan S.A.S
OriginFrance

 

Related Products

Disclaimer

Pharma Solution is the marketing agent and Distributor for the listed products for the Gulf and MENA region. The products are either registered and approved by the  respective local health authority or contracted by the MAH to supply to the end users  on a named patient basis. Some products such  as Orphan drugs, rare diseases medicines are imported based on special import permits and as per need of the Hospitals in compliance with full documentation.

[elfsight_whatsapp_chat id='1']